Osteoporosis patients avoid bisphosphonates

Patients with osteoporosis are avoiding bisphosphonates because of the rare risk for atypical fracture.

Use of the drug fell by 50% from 2008 to 2012, according to a recent paper, and doctors say the trend is continuing, the New York Times reports.

In May, the American Society for Bone and Mineral Research, the National Osteoporosis Foundation and the National Bone Health Alliance